-
dataset
BMI-Related Prescription Costs (2014 Chinese yuan) a, b.
-
dataset
Clinical Input Variables.
-
dataset
Annual Direct Medical Costs for Diabetes-Related Complications (2014 Chinese Yuan).
-
dataset
Demographic and Risk Factors.
-
dataset
Utility decrements.
-
dataset
ObjectiveThis study assessed the long-term cost-effectiveness of saxagliptin+metformin (SAXA+MET) versus acarbose+metformin (ACAR+MET) in Chinese patients with type 2 diabetes...
-
dataset
Annual Treatment Costs (2014 Chinese yuan).
-
dataset
Base Case Results for Saxagliptin plus Metformin Compared with Acarbose plus Metformin (2014 Chinese yuan).